US2005130950A1PendingUtilityA1
Method for improving treatment selectivity and efficacy using intravascular photodynamic therapy
Priority: May 31, 2001Filed: Nov 4, 2004Published: Jun 16, 2005
Est. expiryMay 31, 2021(expired)· nominal 20-yr term from priority
Inventors:Steven J. Rychnovsky
A61K 41/0071A61N 5/0601A61N 5/062A61K 41/0076
59
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
A method in which photodynamic therapy is employed to inhibit, stabilize or reduce occlusions within the cardiovascular system by utilizing light within the spectral region of approximately 390 to approximately 610 nm.
Claims
exact text as granted — not AI-modified1 . A method of PDT treatment employed to inhibit, stabilize or reduce occlusions within the cardiovascular system comprising the steps of:
administering a photosensitizer drug other than psoralen compounds; and delivering an intravascular photoactivating light to the blood vessel at an activiation wavelength within the range of about 390 to 610 nm such that the molar extinction coefficient of the photosensitizer drug at the activation wavelength is at least 1000 L cm −1 M −1 .
2 . A method of PDT treatment employed to inhibit, stabilize or reduce occlusions within the cardiovascular system comprising the steps of:
administering a photosensitizer drug; and delivering a photoactivating light to the blood vessel with an intravascular light delivering device at an activation wavelength within the range of about 440 to 610 nm such that the molar extinction coefficient of said drug at the activation is at least 1000 L cm −1 M −1 .Join the waitlist — get patent alerts
Track US2005130950A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.